nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—type 2 diabetes mellitus	0.221	0.614	CbGaD
Fingolimod—CYP3A4—type 2 diabetes mellitus	0.139	0.386	CbGaD
Fingolimod—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0261	0.101	CbGbCtD
Fingolimod—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0258	0.0998	CbGbCtD
Fingolimod—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0241	0.0934	CbGbCtD
Fingolimod—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.023	0.089	CbGbCtD
Fingolimod—CYP3A4—Glipizide—type 2 diabetes mellitus	0.021	0.0814	CbGbCtD
Fingolimod—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0198	0.0767	CbGbCtD
Fingolimod—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.019	0.0735	CbGbCtD
Fingolimod—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0184	0.0711	CbGbCtD
Fingolimod—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0166	0.0643	CbGbCtD
Fingolimod—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0126	0.0488	CbGbCtD
Fingolimod—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0121	0.0467	CbGbCtD
Fingolimod—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0121	0.0467	CbGbCtD
Fingolimod—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0114	0.0442	CbGbCtD
Fingolimod—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00851	0.0329	CbGbCtD
Fingolimod—CYP3A4—Losartan—type 2 diabetes mellitus	0.00778	0.0301	CbGbCtD
Fingolimod—S1PR1—endothelium—type 2 diabetes mellitus	0.00602	0.0911	CbGeAlD
Fingolimod—S1PR4—adipose tissue—type 2 diabetes mellitus	0.00355	0.0537	CbGeAlD
Fingolimod—CYP4F2—nephron tubule—type 2 diabetes mellitus	0.00353	0.0534	CbGeAlD
Fingolimod—SPHK1—islet of Langerhans—type 2 diabetes mellitus	0.00339	0.0513	CbGeAlD
Fingolimod—CYP4F2—kidney—type 2 diabetes mellitus	0.0031	0.0469	CbGeAlD
Fingolimod—CYP4F2—cortex of kidney—type 2 diabetes mellitus	0.00302	0.0457	CbGeAlD
Fingolimod—SPHK1—retina—type 2 diabetes mellitus	0.0029	0.0439	CbGeAlD
Fingolimod—S1PR3—cardiovascular system—type 2 diabetes mellitus	0.00281	0.0425	CbGeAlD
Fingolimod—S1PR3—pancreas—type 2 diabetes mellitus	0.00273	0.0413	CbGeAlD
Fingolimod—CYP4F12—nephron tubule—type 2 diabetes mellitus	0.00262	0.0397	CbGeAlD
Fingolimod—S1PR3—adipose tissue—type 2 diabetes mellitus	0.00248	0.0375	CbGeAlD
Fingolimod—S1PR1—cardiovascular system—type 2 diabetes mellitus	0.00248	0.0375	CbGeAlD
Fingolimod—SPHK1—cardiovascular system—type 2 diabetes mellitus	0.00245	0.0371	CbGeAlD
Fingolimod—SPHK1—kidney—type 2 diabetes mellitus	0.0024	0.0363	CbGeAlD
Fingolimod—CYP4F12—pancreas—type 2 diabetes mellitus	0.00229	0.0346	CbGeAlD
Fingolimod—CYP4F12—cortex of kidney—type 2 diabetes mellitus	0.00224	0.034	CbGeAlD
Fingolimod—S1PR1—adipose tissue—type 2 diabetes mellitus	0.00218	0.0331	CbGeAlD
Fingolimod—SPHK1—adipose tissue—type 2 diabetes mellitus	0.00216	0.0327	CbGeAlD
Fingolimod—S1PR5—liver—type 2 diabetes mellitus	0.00209	0.0316	CbGeAlD
Fingolimod—CYP4F12—adipose tissue—type 2 diabetes mellitus	0.00208	0.0314	CbGeAlD
Fingolimod—CYP4F2—liver—type 2 diabetes mellitus	0.00196	0.0297	CbGeAlD
Fingolimod—S1PR3—liver—type 2 diabetes mellitus	0.00174	0.0263	CbGeAlD
Fingolimod—S1PR1—liver—type 2 diabetes mellitus	0.00153	0.0232	CbGeAlD
Fingolimod—CYP4F12—liver—type 2 diabetes mellitus	0.00146	0.022	CbGeAlD
Fingolimod—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000442	0.00669	CbGeAlD
Fingolimod—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000397	0.00601	CbGeAlD
Fingolimod—CYP2E1—kidney—type 2 diabetes mellitus	0.000389	0.00588	CbGeAlD
Fingolimod—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000378	0.00573	CbGeAlD
Fingolimod—CYP3A4—kidney—type 2 diabetes mellitus	0.000313	0.00473	CbGeAlD
Fingolimod—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000312	0.00203	CcSEcCtD
Fingolimod—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000311	0.00203	CcSEcCtD
Fingolimod—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000311	0.00203	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00203	CcSEcCtD
Fingolimod—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00202	CcSEcCtD
Fingolimod—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00202	CcSEcCtD
Fingolimod—Infestation NOS—Orlistat—type 2 diabetes mellitus	0.00031	0.00202	CcSEcCtD
Fingolimod—Infestation—Orlistat—type 2 diabetes mellitus	0.00031	0.00202	CcSEcCtD
Fingolimod—Depression—Orlistat—type 2 diabetes mellitus	0.000309	0.00202	CcSEcCtD
Fingolimod—CYP2D6—kidney—type 2 diabetes mellitus	0.000308	0.00466	CbGeAlD
Fingolimod—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000306	0.002	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000303	0.00198	CcSEcCtD
Fingolimod—Influenza—Irbesartan—type 2 diabetes mellitus	0.000302	0.00197	CcSEcCtD
Fingolimod—Alopecia—Glyburide—type 2 diabetes mellitus	0.000301	0.00197	CcSEcCtD
Fingolimod—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000301	0.00196	CcSEcCtD
Fingolimod—Infection—Pioglitazone—type 2 diabetes mellitus	0.0003	0.00196	CcSEcCtD
Fingolimod—Headache—Tolazamide—type 2 diabetes mellitus	0.000297	0.00194	CcSEcCtD
Fingolimod—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000297	0.00194	CcSEcCtD
Fingolimod—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000296	0.00193	CcSEcCtD
Fingolimod—Headache—Linagliptin—type 2 diabetes mellitus	0.000294	0.00192	CcSEcCtD
Fingolimod—Sinusitis—Valsartan—type 2 diabetes mellitus	0.000294	0.00192	CcSEcCtD
Fingolimod—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000293	0.00191	CcSEcCtD
Fingolimod—Infection—Sitagliptin—type 2 diabetes mellitus	0.000291	0.0019	CcSEcCtD
Fingolimod—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000291	0.0019	CcSEcCtD
Fingolimod—Sinusitis—Orlistat—type 2 diabetes mellitus	0.00029	0.0019	CcSEcCtD
Fingolimod—Cerebrovascular accident—Ramipril—type 2 diabetes mellitus	0.000288	0.00188	CcSEcCtD
Fingolimod—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00187	CcSEcCtD
Fingolimod—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000286	0.00187	CcSEcCtD
Fingolimod—Infestation NOS—Metformin—type 2 diabetes mellitus	0.000285	0.00186	CcSEcCtD
Fingolimod—Infestation—Metformin—type 2 diabetes mellitus	0.000285	0.00186	CcSEcCtD
Fingolimod—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000284	0.00186	CcSEcCtD
Fingolimod—Influenza—Losartan—type 2 diabetes mellitus	0.000284	0.00186	CcSEcCtD
Fingolimod—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000283	0.00185	CcSEcCtD
Fingolimod—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000281	0.00183	CcSEcCtD
Fingolimod—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00183	CcSEcCtD
Fingolimod—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00028	0.00183	CcSEcCtD
Fingolimod—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000276	0.0018	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000274	0.00179	CcSEcCtD
Fingolimod—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000274	0.00179	CcSEcCtD
Fingolimod—Bronchitis—Losartan—type 2 diabetes mellitus	0.000273	0.00178	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000272	0.00177	CcSEcCtD
Fingolimod—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000271	0.00177	CcSEcCtD
Fingolimod—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000269	0.00176	CcSEcCtD
Fingolimod—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000269	0.00176	CcSEcCtD
Fingolimod—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000268	0.00175	CcSEcCtD
Fingolimod—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000266	0.00173	CcSEcCtD
Fingolimod—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000264	0.00172	CcSEcCtD
Fingolimod—Infection—Bromocriptine—type 2 diabetes mellitus	0.000263	0.00172	CcSEcCtD
Fingolimod—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000262	0.00171	CcSEcCtD
Fingolimod—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000261	0.0017	CcSEcCtD
Fingolimod—Bradycardia—Metformin—type 2 diabetes mellitus	0.000261	0.0017	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Fingolimod—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Fingolimod—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Fingolimod—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Fingolimod—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Fingolimod—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000258	0.00168	CcSEcCtD
Fingolimod—Back pain—Gliclazide—type 2 diabetes mellitus	0.000258	0.00168	CcSEcCtD
Fingolimod—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00168	CcSEcCtD
Fingolimod—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000255	0.00167	CcSEcCtD
Fingolimod—Pneumonia—Losartan—type 2 diabetes mellitus	0.000255	0.00166	CcSEcCtD
Fingolimod—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000254	0.00166	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000254	0.00166	CcSEcCtD
Fingolimod—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000253	0.00166	CcSEcCtD
Fingolimod—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000253	0.00165	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00165	CcSEcCtD
Fingolimod—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00165	CcSEcCtD
Fingolimod—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000252	0.00164	CcSEcCtD
Fingolimod—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.00025	0.00164	CcSEcCtD
Fingolimod—Alopecia—Valsartan—type 2 diabetes mellitus	0.000249	0.00162	CcSEcCtD
Fingolimod—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000248	0.00162	CcSEcCtD
Fingolimod—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000246	0.00161	CcSEcCtD
Fingolimod—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000246	0.00161	CcSEcCtD
Fingolimod—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000246	0.00161	CcSEcCtD
Fingolimod—CYP2E1—liver—type 2 diabetes mellitus	0.000246	0.00372	CbGeAlD
Fingolimod—Alopecia—Orlistat—type 2 diabetes mellitus	0.000246	0.0016	CcSEcCtD
Fingolimod—Influenza—Ramipril—type 2 diabetes mellitus	0.000244	0.00159	CcSEcCtD
Fingolimod—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000243	0.00159	CcSEcCtD
Fingolimod—Eye disorder—Metformin—type 2 diabetes mellitus	0.000239	0.00156	CcSEcCtD
Fingolimod—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000239	0.00156	CcSEcCtD
Fingolimod—Headache—Repaglinide—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Fingolimod—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Sinusitis—Losartan—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000238	0.00155	CcSEcCtD
Fingolimod—Back pain—Valsartan—type 2 diabetes mellitus	0.000237	0.00155	CcSEcCtD
Fingolimod—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000236	0.00154	CcSEcCtD
Fingolimod—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000235	0.00154	CcSEcCtD
Fingolimod—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000234	0.00153	CcSEcCtD
Fingolimod—Back pain—Orlistat—type 2 diabetes mellitus	0.000234	0.00153	CcSEcCtD
Fingolimod—Cough—Gliclazide—type 2 diabetes mellitus	0.000233	0.00152	CcSEcCtD
Fingolimod—Angiopathy—Metformin—type 2 diabetes mellitus	0.000232	0.00152	CcSEcCtD
Fingolimod—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000231	0.00151	CcSEcCtD
Fingolimod—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000231	0.00151	CcSEcCtD
Fingolimod—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00023	0.0015	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00149	CcSEcCtD
Fingolimod—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00149	CcSEcCtD
Fingolimod—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000228	0.00149	CcSEcCtD
Fingolimod—Hypotension—Glyburide—type 2 diabetes mellitus	0.000226	0.00148	CcSEcCtD
Fingolimod—Asthenia—Glipizide—type 2 diabetes mellitus	0.000226	0.00147	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000225	0.00147	CcSEcCtD
Fingolimod—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00147	CcSEcCtD
Fingolimod—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000224	0.00146	CcSEcCtD
Fingolimod—Pruritus—Glipizide—type 2 diabetes mellitus	0.000223	0.00145	CcSEcCtD
Fingolimod—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000219	0.00143	CcSEcCtD
Fingolimod—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000218	0.00142	CcSEcCtD
Fingolimod—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000217	0.00142	CcSEcCtD
Fingolimod—Palpitations—Valsartan—type 2 diabetes mellitus	0.000216	0.00141	CcSEcCtD
Fingolimod—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000216	0.00141	CcSEcCtD
Fingolimod—Infection—Gliclazide—type 2 diabetes mellitus	0.000216	0.00141	CcSEcCtD
Fingolimod—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000216	0.00141	CcSEcCtD
Fingolimod—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000215	0.00141	CcSEcCtD
Fingolimod—Palpitations—Orlistat—type 2 diabetes mellitus	0.000214	0.0014	CcSEcCtD
Fingolimod—Cough—Valsartan—type 2 diabetes mellitus	0.000214	0.0014	CcSEcCtD
Fingolimod—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000213	0.00139	CcSEcCtD
Fingolimod—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000211	0.00138	CcSEcCtD
Fingolimod—Cough—Orlistat—type 2 diabetes mellitus	0.000211	0.00138	CcSEcCtD
Fingolimod—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000211	0.00138	CcSEcCtD
Fingolimod—Vision blurred—Metformin—type 2 diabetes mellitus	0.00021	0.00137	CcSEcCtD
Fingolimod—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00137	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000209	0.00137	CcSEcCtD
Fingolimod—Dizziness—Glipizide—type 2 diabetes mellitus	0.000208	0.00136	CcSEcCtD
Fingolimod—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000208	0.00136	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000207	0.00135	CcSEcCtD
Fingolimod—Angiopathy—Losartan—type 2 diabetes mellitus	0.000206	0.00135	CcSEcCtD
Fingolimod—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000206	0.00135	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000205	0.00134	CcSEcCtD
Fingolimod—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000204	0.00133	CcSEcCtD
Fingolimod—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Fingolimod—Alopecia—Losartan—type 2 diabetes mellitus	0.000201	0.00131	CcSEcCtD
Fingolimod—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000201	0.00131	CcSEcCtD
Fingolimod—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0002	0.00131	CcSEcCtD
Fingolimod—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000199	0.0013	CcSEcCtD
Fingolimod—Infection—Valsartan—type 2 diabetes mellitus	0.000199	0.0013	CcSEcCtD
Fingolimod—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000198	0.00129	CcSEcCtD
Fingolimod—CYP3A4—liver—type 2 diabetes mellitus	0.000198	0.00299	CbGeAlD
Fingolimod—Headache—Glipizide—type 2 diabetes mellitus	0.000197	0.00129	CcSEcCtD
Fingolimod—Palpitations—Metformin—type 2 diabetes mellitus	0.000197	0.00129	CcSEcCtD
Fingolimod—Infection—Orlistat—type 2 diabetes mellitus	0.000196	0.00128	CcSEcCtD
Fingolimod—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000196	0.00128	CcSEcCtD
Fingolimod—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Fingolimod—CYP2D6—liver—type 2 diabetes mellitus	0.000194	0.00294	CbGeAlD
Fingolimod—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Fingolimod—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Fingolimod—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Fingolimod—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000194	0.00126	CcSEcCtD
Fingolimod—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00126	CcSEcCtD
Fingolimod—Hypertension—Metformin—type 2 diabetes mellitus	0.000192	0.00126	CcSEcCtD
Fingolimod—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000192	0.00125	CcSEcCtD
Fingolimod—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000192	0.00125	CcSEcCtD
Fingolimod—Back pain—Losartan—type 2 diabetes mellitus	0.000192	0.00125	CcSEcCtD
Fingolimod—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00124	CcSEcCtD
Fingolimod—Headache—Pioglitazone—type 2 diabetes mellitus	0.000189	0.00123	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000189	0.00123	CcSEcCtD
Fingolimod—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000188	0.00123	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000188	0.00123	CcSEcCtD
Fingolimod—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Fingolimod—Hypotension—Valsartan—type 2 diabetes mellitus	0.000187	0.00122	CcSEcCtD
Fingolimod—Vision blurred—Losartan—type 2 diabetes mellitus	0.000187	0.00122	CcSEcCtD
Fingolimod—Headache—Glimepiride—type 2 diabetes mellitus	0.000184	0.0012	CcSEcCtD
Fingolimod—Cough—Irbesartan—type 2 diabetes mellitus	0.000184	0.0012	CcSEcCtD
Fingolimod—Headache—Sitagliptin—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Fingolimod—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000182	0.00119	CcSEcCtD
Fingolimod—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000181	0.00118	CcSEcCtD
Fingolimod—Infection—Metformin—type 2 diabetes mellitus	0.000181	0.00118	CcSEcCtD
Fingolimod—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000179	0.00117	CcSEcCtD
Fingolimod—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Fingolimod—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000178	0.00116	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000178	0.00116	CcSEcCtD
Fingolimod—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fingolimod—Leukopenia—Losartan—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fingolimod—Skin disorder—Metformin—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Fingolimod—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000176	0.00115	CcSEcCtD
Fingolimod—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00114	CcSEcCtD
Fingolimod—Palpitations—Losartan—type 2 diabetes mellitus	0.000175	0.00114	CcSEcCtD
Fingolimod—Asthenia—Glyburide—type 2 diabetes mellitus	0.000174	0.00113	CcSEcCtD
Fingolimod—Cough—Losartan—type 2 diabetes mellitus	0.000173	0.00113	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00113	CcSEcCtD
Fingolimod—Alopecia—Ramipril—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Fingolimod—Fatigue—Valsartan—type 2 diabetes mellitus	0.000172	0.00112	CcSEcCtD
Fingolimod—Pruritus—Glyburide—type 2 diabetes mellitus	0.000171	0.00112	CcSEcCtD
Fingolimod—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000171	0.00112	CcSEcCtD
Fingolimod—Infection—Irbesartan—type 2 diabetes mellitus	0.000171	0.00111	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00017	0.00111	CcSEcCtD
Fingolimod—Fatigue—Orlistat—type 2 diabetes mellitus	0.00017	0.00111	CcSEcCtD
Fingolimod—Hypotension—Metformin—type 2 diabetes mellitus	0.00017	0.00111	CcSEcCtD
Fingolimod—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000168	0.0011	CcSEcCtD
Fingolimod—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000167	0.00109	CcSEcCtD
Fingolimod—Headache—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00108	CcSEcCtD
Fingolimod—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000166	0.00108	CcSEcCtD
Fingolimod—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Fingolimod—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000162	0.00106	CcSEcCtD
Fingolimod—Infection—Losartan—type 2 diabetes mellitus	0.000161	0.00105	CcSEcCtD
Fingolimod—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Fingolimod—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000158	0.00103	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Fingolimod—Fatigue—Metformin—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Fingolimod—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000156	0.00102	CcSEcCtD
Fingolimod—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Fingolimod—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000154	0.001	CcSEcCtD
Fingolimod—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000153	0.001	CcSEcCtD
Fingolimod—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000152	0.000992	CcSEcCtD
Fingolimod—Headache—Glyburide—type 2 diabetes mellitus	0.000152	0.000991	CcSEcCtD
Fingolimod—Hypotension—Losartan—type 2 diabetes mellitus	0.000151	0.000986	CcSEcCtD
Fingolimod—Palpitations—Ramipril—type 2 diabetes mellitus	0.00015	0.00098	CcSEcCtD
Fingolimod—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000149	0.000972	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000148	0.000968	CcSEcCtD
Fingolimod—Cough—Ramipril—type 2 diabetes mellitus	0.000148	0.000967	CcSEcCtD
Fingolimod—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000148	0.000967	CcSEcCtD
Fingolimod—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000145	0.000948	CcSEcCtD
Fingolimod—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000144	0.000941	CcSEcCtD
Fingolimod—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000144	0.000939	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000144	0.000937	CcSEcCtD
Fingolimod—Asthenia—Valsartan—type 2 diabetes mellitus	0.000143	0.000936	CcSEcCtD
Fingolimod—Asthenia—Orlistat—type 2 diabetes mellitus	0.000142	0.000925	CcSEcCtD
Fingolimod—Pruritus—Valsartan—type 2 diabetes mellitus	0.000141	0.000923	CcSEcCtD
Fingolimod—Pruritus—Orlistat—type 2 diabetes mellitus	0.00014	0.000912	CcSEcCtD
Fingolimod—Fatigue—Losartan—type 2 diabetes mellitus	0.000139	0.00091	CcSEcCtD
Fingolimod—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000137	0.000893	CcSEcCtD
Fingolimod—Headache—Gliclazide—type 2 diabetes mellitus	0.000136	0.00089	CcSEcCtD
Fingolimod—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000136	0.000887	CcSEcCtD
Fingolimod—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000135	0.000882	CcSEcCtD
Fingolimod—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.000879	CcSEcCtD
Fingolimod—Dizziness—Valsartan—type 2 diabetes mellitus	0.000132	0.000863	CcSEcCtD
Fingolimod—Dizziness—Orlistat—type 2 diabetes mellitus	0.000131	0.000853	CcSEcCtD
Fingolimod—Asthenia—Metformin—type 2 diabetes mellitus	0.000131	0.000852	CcSEcCtD
Fingolimod—Hypotension—Ramipril—type 2 diabetes mellitus	0.000129	0.000845	CcSEcCtD
Fingolimod—Pruritus—Metformin—type 2 diabetes mellitus	0.000129	0.000841	CcSEcCtD
Fingolimod—Headache—Valsartan—type 2 diabetes mellitus	0.000125	0.000817	CcSEcCtD
Fingolimod—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000124	0.000813	CcSEcCtD
Fingolimod—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000124	0.000812	CcSEcCtD
Fingolimod—Headache—Orlistat—type 2 diabetes mellitus	0.000124	0.000808	CcSEcCtD
Fingolimod—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000124	0.000807	CcSEcCtD
Fingolimod—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000804	CcSEcCtD
Fingolimod—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000121	0.000793	CcSEcCtD
Fingolimod—Dizziness—Metformin—type 2 diabetes mellitus	0.00012	0.000786	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000781	CcSEcCtD
Fingolimod—Fatigue—Ramipril—type 2 diabetes mellitus	0.000119	0.00078	CcSEcCtD
Fingolimod—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000117	0.000767	CcSEcCtD
Fingolimod—Asthenia—Losartan—type 2 diabetes mellitus	0.000116	0.000757	CcSEcCtD
Fingolimod—Pruritus—Losartan—type 2 diabetes mellitus	0.000114	0.000747	CcSEcCtD
Fingolimod—Headache—Metformin—type 2 diabetes mellitus	0.000114	0.000744	CcSEcCtD
Fingolimod—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000114	0.000741	CcSEcCtD
Fingolimod—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000111	0.000722	CcSEcCtD
Fingolimod—Headache—Irbesartan—type 2 diabetes mellitus	0.000108	0.000702	CcSEcCtD
Fingolimod—Dizziness—Losartan—type 2 diabetes mellitus	0.000107	0.000698	CcSEcCtD
Fingolimod—Headache—Losartan—type 2 diabetes mellitus	0.000101	0.000661	CcSEcCtD
Fingolimod—Asthenia—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000649	CcSEcCtD
Fingolimod—Pruritus—Ramipril—type 2 diabetes mellitus	9.8e-05	0.00064	CcSEcCtD
Fingolimod—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.48e-05	0.000619	CcSEcCtD
Fingolimod—Dizziness—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000598	CcSEcCtD
Fingolimod—Headache—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000567	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.04e-05	6.4e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-05	6.31e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.03e-05	6.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	1.02e-05	6.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	1.02e-05	6.29e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-05	6.2e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-05	6.2e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCC8—type 2 diabetes mellitus	1e-05	6.15e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CBS—type 2 diabetes mellitus	1e-05	6.15e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.99e-06	6.13e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.9e-06	6.08e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.9e-06	6.08e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.84e-06	6.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	9.78e-06	6e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.74e-06	5.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A2—type 2 diabetes mellitus	9.63e-06	5.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COX2—type 2 diabetes mellitus	9.63e-06	5.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA6—type 2 diabetes mellitus	9.47e-06	5.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—UCP3—type 2 diabetes mellitus	9.31e-06	5.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HSD11B1—type 2 diabetes mellitus	9.31e-06	5.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—UCP2—type 2 diabetes mellitus	9.31e-06	5.71e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.17e-06	5.63e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—type 2 diabetes mellitus	9.09e-06	5.58e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.08e-06	5.57e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	9.02e-06	5.54e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	9.02e-06	5.54e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.99e-06	5.52e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.84e-06	5.43e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	8.75e-06	5.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	8.71e-06	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	8.71e-06	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	8.71e-06	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.71e-06	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	8.71e-06	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	8.44e-06	5.18e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	8.19e-06	5.03e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.11e-06	4.98e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	8.09e-06	4.97e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	7.97e-06	4.89e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	7.97e-06	4.89e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.95e-06	4.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	7.91e-06	4.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.91e-06	4.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.91e-06	4.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	7.91e-06	4.86e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.9e-06	4.85e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—type 2 diabetes mellitus	7.85e-06	4.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	7.77e-06	4.77e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—type 2 diabetes mellitus	7.61e-06	4.67e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.61e-06	4.67e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	7.59e-06	4.66e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	7.41e-06	4.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	7.41e-06	4.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	7.41e-06	4.55e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.29e-06	4.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	7.1e-06	4.36e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	7.1e-06	4.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	7.07e-06	4.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	7.07e-06	4.34e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	7.05e-06	4.33e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.02e-06	4.31e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.02e-06	4.31e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.91e-06	4.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	6.84e-06	4.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	6.84e-06	4.2e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—type 2 diabetes mellitus	6.74e-06	4.14e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	6.72e-06	4.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.7e-06	4.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.7e-06	4.11e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	6.6e-06	4.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	6.6e-06	4.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	6.6e-06	4.06e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.58e-06	4.04e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	6.45e-06	3.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	6.45e-06	3.96e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.39e-06	3.92e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.37e-06	3.91e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	6.33e-06	3.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	6.29e-06	3.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	6.29e-06	3.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	6.29e-06	3.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.25e-06	3.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	6.21e-06	3.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.13e-06	3.77e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.11e-06	3.75e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	6.06e-06	3.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.9e-06	3.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.9e-06	3.62e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	5.81e-06	3.57e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.7e-06	3.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.7e-06	3.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.7e-06	3.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.7e-06	3.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.7e-06	3.5e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.64e-06	3.46e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	5.64e-06	3.46e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	5.64e-06	3.46e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	5.64e-06	3.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	5.61e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	5.61e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	5.61e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	5.61e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	5.53e-06	3.4e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.52e-06	3.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	5.48e-06	3.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	5.38e-06	3.31e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.37e-06	3.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.21e-06	3.2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.21e-06	3.2e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.1e-06	3.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.1e-06	3.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.08e-06	3.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5e-06	3.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.97e-06	3.05e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	4.89e-06	3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.89e-06	3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.84e-06	2.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.84e-06	2.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.84e-06	2.97e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	4.67e-06	2.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.64e-06	2.85e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.64e-06	2.85e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	4.58e-06	2.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	4.58e-06	2.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.49e-06	2.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.47e-06	2.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.47e-06	2.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.46e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.46e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.46e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.43e-06	2.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.39e-06	2.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.35e-06	2.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.32e-06	2.65e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.32e-06	2.65e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.32e-06	2.65e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.3e-06	2.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.21e-06	2.59e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.21e-06	2.59e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.19e-06	2.58e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.14e-06	2.54e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.06e-06	2.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.02e-06	2.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4e-06	2.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4e-06	2.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4e-06	2.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.93e-06	2.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	3.91e-06	2.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.89e-06	2.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	3.84e-06	2.36e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.81e-06	2.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.8e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.76e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.74e-06	2.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.67e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.67e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.67e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.67e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.66e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.64e-06	2.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.62e-06	2.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.62e-06	2.22e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.6e-06	2.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.53e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.52e-06	2.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.47e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.47e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.45e-06	2.12e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.39e-06	2.08e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.28e-06	2.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.27e-06	2.01e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.23e-06	1.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.22e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.18e-06	1.95e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.05e-06	1.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.99e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.99e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.99e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.99e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.98e-06	1.83e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.94e-06	1.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.93e-06	1.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.92e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.92e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.92e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.9e-06	1.78e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.85e-06	1.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.85e-06	1.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.81e-06	1.73e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.8e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.77e-06	1.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.75e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.72e-06	1.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.66e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.66e-06	1.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.62e-06	1.61e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.62e-06	1.61e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.62e-06	1.61e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.59e-06	1.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.57e-06	1.58e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.55e-06	1.57e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.54e-06	1.56e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.49e-06	1.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.45e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	1.48e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	1.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-06	1.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.39e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.37e-06	1.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.37e-06	1.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.33e-06	1.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.29e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.28e-06	1.4e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.27e-06	1.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.27e-06	1.39e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.26e-06	1.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.2e-06	1.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.99e-06	1.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.95e-06	1.2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.95e-06	1.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.95e-06	1.2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.95e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.92e-06	1.18e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.86e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.81e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.79e-06	1.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.78e-06	1.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.74e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.74e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.71e-06	1.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.71e-06	1.05e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.69e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.67e-06	1.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.6e-06	9.84e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.57e-06	9.65e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	9.6e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.52e-06	9.35e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.5e-06	9.19e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.49e-06	9.16e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.47e-06	9.06e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.3e-06	7.98e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.27e-06	7.83e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.17e-06	7.17e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	6.86e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	6.86e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	6.8e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-06	6.28e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.86e-07	4.83e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.14e-07	3.15e-06	CbGpPWpGaD
